QA: Harrow INC in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001360214_2025_Harrow_INC.pdf

Logs

Graph

Absolute values for 0001360214, Harrow INC

  xvar xval
0 AssetsCurrent 189,651,000
1 IntangibleAssetsNetIncludingGoodwill 185,281,000
2 PropertyPlantAndEquipmentNet 3,734,000
3 remainder_Assets 10,305,000
4 LiabilitiesCurrent 91,343,000
5 LiabilitiesNoncurrent 8,792,000
6 remainder_Liabilities 219,539,000
7 CostOfGoodsAndServicesSold 57,831,365
8 SellingGeneralAndAdministrativeExpense 358,748,962
9 ResearchAndDevelopmentExpense 10,302,107
10 remainder_Expenses 462,907
11 remainder_Revenues 546,434,514
12 remainder_NetIncome -25,717,655
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 388,971,000
1 Liabilities 319,674,000
2 Expenses 427,345,341
3 Revenues 546,434,514
4 StockholdersEquity 69,297,000
5 NetIncome 93,371,518
6 ComprehensiveNetIncome 93,371,518
7 BaseVar 854,071,255
8 EconomicCapitalRatiobeforeLimitedLiability 0.690
9 EconomicCapitalRatio 2.05

Edgar->Model Mapping

Feature Distribution

Change over Time